¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019 Á¦15Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ : 2019-05-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019 Á¦15Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ : 2019-05-26
±³À°ÀÏÀÚ : 2019-05-26
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : 2019 Á¦15Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ 
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѸð¹ßÇÐȸ  
´ã´çÀÚ : ÇãâÈÆ
¿¬¶ôó : 031-787-7310  
À̸ÞÀÏ : kda@derma.or.kr      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í Á¤È¸¿ø, ¿¬±¸È¸¿ø(¿¬È¸ºñÆ÷ÇÔ): »çÀüµî·Ï 4¸¸¿ø, ÇöÀåµî·Ï 5¸¸¿øÀüȸ¿ø, ¿¬±¸È¸¿ø(ȸºñ³³ºÎȸ¿ø): »çÀüµî·Ï 2¸¸¿ø, ÇöÀåµî·Ï 3¸¸¿øºñȸ¿ø(ÇǺΰúÀü¹®ÀÇ, °¡ÀÔºñ Æ÷ÇÔ):»çÀüµî·Ï 7¸¸¿ø, ÇöÀåµî·Ï 8¸¸¿øÇǺΰú(Àü°øÀÇ,±ºÀÇ°ü,°øº¸ÀÇ), ¿¬±¸ÁØȸ¿ø: »çÀüµî·Ï 1¸¸¿ø, ÇöÀåµî·Ï 2¸¸¿øÇǺΰú ¿Ü Ÿ°ú ºñȸ¿ø: 50¸¸¿ø(ÇöÀåµî·Ï¸¸ °¡´É)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 09:00~09:15 Epidemiological Studies of Alopecia Areata Using National Health Insurance Service-National Sample Cohort (NHIS-NSC)  ÃÖÁö¿õ(¾ÆÁÖ´ë) 
±âŸ 05-26 ±×·£µåº¼·ë 09:15~09:30 °³È¸½Ä  () 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 09:30~09:45 Skin equivalent assay: an optimized method for testing for hair growth reconstitution capacity of epidermal and dermal cells.  ¹é½Âȯ(¾Æ»êÀÇ·á¿ø) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 09:45~10:00 Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma.  ÀÌ¿µ(Ãæ³²´ë) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 10:00~10:30 Follicle mitochondria as a target for hair loss treatment  Thomas Dawson(A*Star) 
È޽Ġ05-26 ±×·£µåº¼·ë 10:30~10:45 Coffee Break  () 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 10:45~11:05 The kitchen garden roles of DPC cells in bench to clinic for hair disorders.  °­ÈÆ(Ä«Å縯´ë) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 11:10~11:35 Revisiting the pathophysiology of hair loss disorders for better management - a physician-scientist  Manabu Ohyama(Kyorin University) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 11:35~11:45 Quality of life in Korean alopecic patient: nationalwide studies supported by the Korean Hair Research Society  ÃÖ±¤¼º(ÀÎÇÏ´ë) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 11:45~11:55 Neuroendocrine system in hair growth  Koji Sugawara(Osaka City University) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 11:55~12:05 Dermoscopy uses for hair & scalp diseases.  ±è¹®¹ü(ºÎ»ê´ë) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 12:05~12:15 Folliculitis decalvans: Study of clinical and histopathological features  Masaki Uchiyama(Tokyo Medical University) 
½Ä»ç 05-26 ±×·£µåº¼·ë 12:15~13:20 Á¡½É½Ä»ç  () 
Åä·Ð 05-26 ±×·£µåº¼·ë 13:20~14:05 ÀÚÀ¯¿¬Á¦  () 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 14:05~14:35 Efficacy and safety of finasteride for ten years of over 300 AGA patients in Japan.  Akio Sato(Tokyo Memorial Clinic) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 14:35~14:50 The treatment of AGA with 5AR inhibitor in elderly and female patients  À¯¹Ú¸°(°æÈñ´ë) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 14:50~15:05 Tranomic analysis of balding and non-balding scalp in male pattern baldness and female pattern hair loss.  ¹Úº´Ã¶(´Ü±¹´ë) 
È޽Ġ05-26 ±×·£µåº¼·ë 15:05~15:20 Coffee Break  () 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 15:20~15:50 Review Update on Alopecia Areata  Kevin McElwee(Bradford University) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 15:50~16:05 Mechanism: JAK inhibitor and mesenchymal stem cell therapy to treat alopecia areata  ±èÁ¤Àº(Ä«Å縯´ë) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 16:05~16:20 Oral tofacitinib for moderate-to-severe alopecia areata from clinician's view point  ¹ÚÇö¼±(¼­¿ï´ë) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 16:20~16:35 Role of Hair Prostheses (Wigs) in Patients with Severe Alopecia Areata.  ¹ÚÁø(ÀüºÏ´ë) 
±³À°½Ã°£ 05-26 ±×·£µåº¼·ë 16:35~16:50 Therapeutic efficacy and safety of a 1927-nm fractionated thulium laser on pattern hair loss: an evaluator-blinded, split-scalp study.  Á¶¼ººó(¿¬¼¼¼¼¶õÇǺΰú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019 Á¦15Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ : 2019-05-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÇѸ²´ëÇб³°­µ¿¼º½Éº´¿ø 2019³â 5¿ù ºñ´¢ÀÇÇаú ¿¬¼ö°­Á : 2019-05-28
´ÙÀ½±Û 2019³âµµ ´ëÇÑÅëÁõÇÐȸ Ãá°è ¿¬¼ö±³À° : 2019-05-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21135 °æ±â Á¦10Â÷ ¿¬¼¼ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2024-07-31 0 29 2024-06-19
21134 °æ±â 2024 Çѱ¹¼ö¸éÇÐȸ ÇÏ°èÇмú´ëȸ : 2024-07-26 0 49 2024-06-19
21133 ¼­¿ï 2024³â ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Á¦25ȸ Çмú´ëȸ : 2024-07-21 0 36 2024-06-19
21132 ¼­¿ï ´ëÇÑÀÓ»ó¾Ï´ë»çÀÇÇÐȸ 2024³â Ãß°èÇмú´ëȸ IVC¿Í Detox : 2024-07-21 0 33 2024-06-19
21131 ´ë±¸ ´ë±¸°æºÏ³»°úÇÐȸ 2024³â Á¤±âÇмú´ëȸ : 2024-07-21 0 30 2024-06-19
21130 Á¦ÁÖ Á¦13ȸ ´ëÇѳ»ºÐºñÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-07-20 0 20 2024-06-19
21129 ±¤ÁÖ Á¦225Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ ±¤ÁÖÀü³²Áöȸ ¿¬¼ö°­Á : 2024-07-16 0 19 2024-06-19
21128 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦3ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-07-15 0 40 2024-06-19
21127 ¼­¿ï 2024 ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±âÇÐ ¿¬¼ö°­Á : 2024-07-14 0 38 2024-06-19
21126 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑôÃß¿µ»óÀÇÇÐȸ Á¤±â¿¬¼ö°­Á : 2024-07-14 0 26 2024-06-19
21125 ¼­¿ï Á¦29Â÷ Ưº°¿¬¼ö°­Á – »êºÎÀΰú Áúȯ óġÀÇ ÃֽŠÁö°ß : 2024-07-14 0 26 2024-06-19
21124 °­¿ø 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á : 2024-07-14 0 26 2024-06-19
21123 ¼­¿ï 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãá°è ¹Ì¼¼¼ö¼ú ¿öÅ©¼ó : 2024-07-14 0 27 2024-06-19
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 21 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 45 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷